Screener
Travere Therapeutics, Inc. TVTX Business Segments — R&D
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.
The source filing: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:45 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001438533-26-000042
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| External research and development | 27,728 | 22,355 |
| Internal personnel costs | 24,525 | 20,102 |
| Other research and development | 4,841 | 4,432 |
| Total research and development | 57,094 | 46,889 |
| Selling, general and administrative | 80,254 | 60,413 |
| Royalty expense | 24,816 | 12,425 |
| Total other income, net | 193 | 1,487 |
| Income tax benefit (provision) | 120 | (39) |
Item 1. Financial Statements
FAQ
- What is Travere Therapeutics, Inc.'s business segments — R&D?
- Travere Therapeutics, Inc. (TVTX) reported business segments — R&D of $57.09M in Q1 2026.
- How has Travere Therapeutics, Inc.'s business segments — R&D changed year-over-year?
- Travere Therapeutics, Inc.'s business segments — R&D increased by 21.8% year-over-year, from $46.89M to $57.09M.
- What is the long-term trend for Travere Therapeutics, Inc.'s business segments — R&D?
- Over 3 years (2022 to 2025), Travere Therapeutics, Inc.'s business segments — R&D has grown at a -3.2% compound annual growth rate (CAGR), from $227.33M to $206.01M.
- What does business segments — R&D mean?
- This metric aggregates all costs associated with the discovery, development, and clinical testing of the company's therapeutic pipeline. It is a critical measure of the company's commitment to long-term innovation and future product commercialization.
Ask your AI about Travere Therapeutics, Inc.'s business segments — r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude